Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Sun Pharma Q3 net profit declines 27 pc to Rs 914 cr

Feb 6, 2020, 16:49 IST

PTI

New Delhi, Feb 6 () Drug major Sun Pharmaceutical Industries on Thursday reported a 26.43 per cent decline in its consolidated net profit to Rs 913.52 crore for the quarter ended December 31, 2019.

The company had posted a net profit of Rs 1,241.85 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing.

Consolidated income from operations of the company stood at Rs 8,038.65 crore for the quarter under consideration. It was Rs 7,656.71 crore for the same period a year ago.

The company's board has declared an interim dividend of Rs 3 per equity share of Re 1 each, Sun Pharma said.

Shares of Sun Pharmaceutical Industries closed at Rs 430.95 per scrip on the BSE, up 1.13 per cent from its previous close. AKT SHWSHW

(This story has not been edited by www.businessinsider.in and is auto–generated from a syndicated feed we subscribe to.)